Myocardial infarction in major noncardiac surgery: Epidemiology, pathophysiology and prevention

Stefano Lucreziotti1, Francesca Carletti, Giulia Santaguida

  • 1Unità Operativa di Cardiologia, Azienda Ospedaliera S. Paolo, Polo Universitario, Milano - Italy.

Heart International
|October 7, 2011
PubMed

Insights

Major noncardiac surgery poses risks for perioperative myocardial infarction (MI). This review clarifies MI pathophysiology, risk assessment, and management strategies for at-risk surgical patients.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Perioperative Medicine

Background:

  • Growing number of patients undergoing major noncardiac surgery are at risk for perioperative myocardial infarction (MI).
  • An estimated 500,000 to 900,000 patients annually experience major perioperative cardiovascular complications, leading to significant long-term implications and costs.
  • Perioperative MIs have distinct pathophysiology compared to non-surgical MIs, with unclear triggers.

Purpose of the Study:

  • To review the epidemiology, pathophysiology, and management of perioperative myocardial infarction in noncardiac surgery.
  • To discuss current risk stratification methods and prophylactic/therapeutic interventions.
  • To provide insights into optimizing perioperative cardiac care.

Main Methods:

  • Literature review focusing on perioperative myocardial infarction.
  • Analysis of epidemiological data and pathophysiological mechanisms.
  • Evaluation of risk assessment indices and management algorithms.

Main Results:

  • Perioperative MI is a significant concern in noncardiac surgery, with evolving understanding of its causes.
  • Various indices and strategies have been developed for risk stratification and guiding management.
  • Optimal prophylactic and postoperative interventions require further definition.

Conclusions:

  • A comprehensive understanding of perioperative MI is crucial for improving patient outcomes.
  • Risk stratification and tailored management strategies are essential for mitigating cardiac events.
  • Continued research is needed to refine perioperative cardiac care protocols.

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...